Results 111 to 120 of about 32,023 (271)
Acetazolamide in Treatment of Sickle-Cell Anaemia [PDF]
, 1959 L. G. Macdougall, Gitta Jacob
openalex +1 more source
Extracranial-intracranial bypass in atherosclerotic cerebrovascular disease: Report of a single centre experience [PDF]
, 2011 Despite the failure of the international extracranial-intracranial (EC-IC) bypass study in showing the benefit of bypass procedure for prevention of stroke recurrence, it has been regarded to be beneficial in a subgroup of well-selected patients with ...
Bellut, D +4 more
core +1 more source
Brain and Behavior, Volume 15, Issue 6, June 2025.This study provides a literature review exploring the relationship between high‐altitude environmental factors and stroke, analyzes the limitations of current research, and proposes future research directions and preventive measures. ABSTRACT Background Stroke poses a significant social and familial burden on populations worldwide.
Chuanxi Duan +8 more
wiley +1 more source
Miller Fisher Syndrome Presenting as Pseudotumor
Pediatric Neurology Briefs, 2002 Two female children, ages 9 and 2 years, who presented with pseudotumor cerebri and within 2 to 3 days, were diagnosed with Miller Fisher syndrome are reported from the Hopital Universitaire des Enfants Reine Fabiola, Brussels, Belgium.
J Gordon Millichap
doaj +1 more source
, 2001 With microsensors, we measured the steady‐state microprofiles of O2, pH and Ca2+ on the topside of young segments of Halimeda discoidea, as well as the surface dynamics upon light–dark shifts. The effect of several inhibitors was studied.
de Beer, D., Larkum, A.
core
ESC Heart Failure, Volume 12, Issue 3, Page 2023-2033, June 2025.Abstract Aims Dapagliflozin (DAPA), a sodium‐glucose co‐transporter 2 inhibitor, has been shown to reduce cardiovascular mortality among patients with chronic heart failure. We aimed to evaluate the impact on a worsening renal function (WRF) by adding DAPA as compared to standard decongestive therapy with loop diuretics alone.
Shodai Kawanami +11 more
wiley +1 more source
Topiramate Compared to Acetazolamide in Treatment of Idiopathic Intracranial Hypertension
Pediatric Neurology Briefs, 2007 The efficacy of topiramate in the treatment of idiopathic intracranial hypertension (IIH) was compared to acetazolamide in an open-label study of 40 patients (age range 16-50, median 32 years; male/female ratio 5/35) at Ege University Medical School ...
J Gordon Millichap
doaj +1 more source
THE KIDNEY AS A SOURCE OF BLOOD AMMONIA IN PATIENTS WITH LIVER DISEASE: THE EFFECT OF ACETAZOLAMIDE *† [PDF]
, 1960 Edward E. Owen +3 more
openalex +1 more source
Serious Neurologic Adverse Events in Tofersen Clinical Trials for Amyotrophic Lateral Sclerosis
Muscle &Nerve, Volume 71, Issue 6, Page 1006-1015, June 2025.ABSTRACT Introduction/Aims Tofersen is approved for the treatment of amyotrophic lateral sclerosis (ALS) due to superoxide dismutase 1 mutations (SOD1‐ALS). Here we report serious neurologic adverse events (AEs) that occurred in the tofersen clinical trials in people with SOD1‐ALS.
Alexandra Lovett +17 more
wiley +1 more source